Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 21 010 463 751 SEK
- Likvida medel
- 348 522 592 SEK
- Övriga tillgångar och skulder
- 87 544 821 SEK
- Antal innehav
- 59
- Aktiv risk
- 2,51
- Standardavvikelse 24 månader
- 10,95
- Jämförelseindex
- MSCI World Health Care Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| Eli Lilly | 1 825 862 253 SEK | 8,69% | Health Care |
| United Health Group | 1 682 413 554 SEK | 8,01% | Health Care |
| AbbVie | 1 380 676 413 SEK | 6,57% | Health Care |
| Novo Nordisk | 1 294 282 676 SEK | 6,16% | Health Care |
| AstraZeneca | 1 223 426 035 SEK | 5,82% | Health Care |
| Merck | 1 014 381 037 SEK | 4,83% | Health Care |
| Thermo Fisher Scientific | 962 333 022 SEK | 4,58% | Health Care |
| Boston Scientific | 948 685 455 SEK | 4,52% | Health Care |
| Danaher | 903 946 108 SEK | 4,30% | Health Care |
| Abbott Laboratories | 848 004 609 SEK | 4,04% | Health Care |
| HCA Healthcare | 818 330 333 SEK | 3,89% | Health Care |
| Vertex Pharmaceuticals | 768 737 940 SEK | 3,66% | Health Care |
| McKesson | 758 788 397 SEK | 3,61% | Health Care |
| Centene | 478 370 528 SEK | 2,28% | Health Care |
| Merck | 472 037 321 SEK | 2,25% | Health Care |
| Zoetis | 467 129 840 SEK | 2,22% | Health Care |
| Cooper Companies | 382 929 938 SEK | 1,82% | Health Care |
| Roche | 358 976 915 SEK | 1,71% | Health Care |
| Hologic | 319 771 469 SEK | 1,52% | Health Care |
| ICON | 288 111 097 SEK | 1,37% | Health Care |
| Steris | 277 301 520 SEK | 1,32% | Health Care |
| Royalty Pharma | 254 856 050 SEK | 1,21% | Health Care |
| SPDR S&P Biotech ETF | 232 203 569 SEK | 1,11% | ÖV |
| Sanofi | 219 994 534 SEK | 1,05% | Health Care |
| ConvaTec Group | 194 831 289 SEK | 0,93% | Health Care |
Branscher
Källa: Finansinspektionen.